thiamine has been researched along with Muscular Atrophy in 4 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Probert, F | 3 |
Gorlova, A | 3 |
Deikin, A | 3 |
Bettendorff, L | 3 |
Veniaminova, E | 3 |
Nedorubov, A | 3 |
Chaprov, KD | 3 |
Ivanova, TA | 3 |
Anthony, DC | 3 |
Strekalova, T | 3 |
Takusa, Y | 1 |
Hanaoka, S | 1 |
Fukatsu, R | 1 |
Tamura, T | 1 |
Miyachi, T | 1 |
Noda, K | 1 |
Watanabe, C | 1 |
Katayama, S | 1 |
Kaseda, Y | 1 |
Nakamura, S | 1 |
Kito, S | 1 |
Muro, T | 1 |
Tomonaga, M | 1 |
4 other studies available for thiamine and Muscular Atrophy
Article | Year |
---|---|
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Topics: Amyotrophic Lateral Sclerosis; Animals; Glycogen Synthase Kinase 3 beta; Metabolome; Mice; Mice, Tra | 2022 |
[Magnetic resonance imaging in thiamine responsive pyruvate dehydrogenase complex deficiency].
Topics: Acidosis, Lactic; Brain; Child, Preschool; Female; Humans; Intellectual Disability; Magnetic Resonan | 1996 |
[Chronic neuropathy, a high level of protein in cerebrospinal fluid, and vitamin B1 and folate deficiency in a patient with normal-pressure hydrocephalus].
Topics: Aged; Cerebrospinal Fluid Proteins; Chronic Disease; Female; Folic Acid Deficiency; Humans; Hydrocep | 1997 |
[Neuromuscular disorders in diabetes mellitus].
Topics: Adolescent; Adult; Aged; Child; Diabetic Neuropathies; Electromyography; Female; Humans; Male; Middl | 1968 |